Unlock instant, AI-driven research and patent intelligence for your innovation.
Colchicine derivative
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A technology for colchicine and derivatives, applied in the field of colchicine derivatives, can solve problems such as weak effect, and achieve the effects of high cell selectivity and good anti-tumor activity
Active Publication Date: 2015-02-25
ZHEJIANG UNIV
View PDF12 Cites 0 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
[0005] (2) The B ring has a certain affinity with tubulin, but the effect is not strong. The modification of the C-7 side chain of the B ring is mainly used to adjust the pharmacokinetic characteristics of colchicine derivatives
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0110] The synthesis of embodiment 1 compound 1
[0111]
[0112] Compound 1, which converts the C ring of colchicine into aniline, can be synthesized by the classic Fernholz method (see JustusLie bigs Ann. 1950), or it can be synthesized by referring to the method disclosed in the Chinese invention with application number 201210049085.3, and synthesized according to the above chemical reaction equation.
Embodiment 2
[0113] The synthesis of embodiment 2 compound 2
[0114]
[0115] 2.75g of compound 1 was dissolved in 65mL of 0.12M HCl, 13g of sodiumsulfate was added, 2.5g of hydroxylaminehydrochloride and 2.1g of chloral were added successively under stirring, and the reaction was carried out at 55°C for 24 hours. 3 × 50mLEtOAc extraction (that is, extraction 3 times, each time with 50mLEtOAc), anhydrous Na2SO4 drying, silica gelcolumn chromatography (EtOAc / EtOH=10:1, that is, the mobile phase composition is a mixture of EtOAc and EtOH with a volume ratio of 10:1 liquid), to obtain 3.3 g (yield 100%) of product 2 as a light yellow solid.
[0116] Compound 2H-NMR (500MHz, d 6 -DMSO): 1.90 (1H, s), 1.94 (1H, m), 2.0~2.2 (2H, m), 2.54 (1H, m), 3.49 (3H, s), 3.79 (3H, s), 3.84 ( 3H,s),4.49(1H,m),6.78(1H,s),7.28(1H,d),7.63(1H,dd),7.67(1H,d),7.72(1H,s),8.42(1H ,d), 10.24(1H,s), 12.19(1H,s). Compound 2 HRMS (high resolutionmass spectrometry): C 22 h 25 N 3 o 6 Na + Theoretical va...
Embodiment 3
[0117] The synthesis of embodiment 3 compound 3 and compound 4
[0118]
[0119] 95mL of methanesulfonic acid was preheated to 40°C, 2.5g of compound 2 was added under stirring, the temperature was slowly raised to 85°C, and the reaction was carried out for 1 hour. After cooling, it was poured into 500mL ice water, extracted with 10×50mL EtOAc, washed with saturated brine, saturated aqueous sodiumbicarbonate solution, saturated brine, and anhydrous Na 2 SO 4 Drying, silica gelcolumn chromatography (CH 2 Cl 2 / MeOH=10:1), 1.0 g (yield 36%) of red solid product compound 3 and 0.3 g (yield 10%) of compound 4 were obtained.
[0120] Compound 3H-NMR (500MHz, d 6 -DMSO): 1.89 (3H, s), 1.96 (1H, m), 2.1~2.2 (2H, m), 2.56 (1H, m), 3.52, (3H, s), 3.79 (3H, s), 3.84 (3H, s), 4.47 (1H, m), 6.80 (1H, s), 6.89 (1H, s), 7.37 (1H, s), 8.56 (1H, d, J8Hz), 11.09 (1H, s).
[0121] Compound 3 HRMS: C 22 h 22 N 2 o 6 The theoretical value is 410.1478; the measured value is 410.1479...
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
PUM
Login to View More
Abstract
The present invention discloses a colchicine derivative, which has a structure formula represented by a formula (I), wherein R is hydrogen, an optionally substituted hydrocarbon group and an optionally substituted heterocyclic group, R1 is H, an optionally substituted hydrocarbon group, an optionally substituted heterocyclic group, an acyl group, a sulfonyl group and a substituted formyl group, R2 and R3 independently are H, an optionally substituted hydrocarbon group, an optionally substituted heterocyclic group, an acyl group, a substituted formyl group, a carboxyl group and a sulfonyl group, R4 and R5 independently are H, an optionally substituted hydrocarbon group, an optionally substituted heterocyclic group, a substituted oxyl group and an acyl group, R6 is hydrogen, an optionally substituted C1-C6 aliphatic hydrocarbon group and a substituted oxyl group, R7 is hydrogen, an optionally substituted C1-C6 aliphatic hydrocarbon group, a substituted oxyl group, an acyl group and a substituted formyl group, and R6R7 is a covalent bond. The colchicine derivative has a good anti-tumor activity and high cell selectivity, and can be expected to be a cell-specific drug with a low toxic-side effect.
Description
technical field [0001] The invention relates to the field of drugs with antitumor activity, in particular to a colchicine derivative. Background technique [0002] Colchicine is a natural alkaloid that can also be synthesized artificially. It is commonly used clinically to treat acute gout (ac utegout), familial Mediterranean fever (familial Mediterranean fever), scleroderma (seleroderma), Behcet's disease (Behcet's disease), liver cirrhosis (cirrhosi), etc., and its effective dose is 0.015 mg / kg, the toxic dose is about 0.1 mg / kg, and the lethal dose is 0.8 mg / kg, with large toxic and side effects and low therapeutic index. [0003] Colchicine mainly acts on tubulin, and it can combine with tubulin to destabilize tubulin, showing strong anti-tumor activity in vitro and a broad anti-tumor spectrum, but due to its high toxicity, it cannot be used in the clinical practice of cancer. applied in treatment. In order to obtain colchicine derivatives with high activity and low t...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to View More 
Login to View More 
